Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

ALSUntangled does not advise ketogenic diets as an ALS treatment

Original source

Ketogenic DietsALSUntangled · 21 October 2021 (opens in a new tab)

ALSUntangled reviewed the evidence for ketogenic diets in amyotrophic lateral sclerosis (ALS) and found no reliable evidence of benefit. Reported benefits came from one flawed preclinical study and two PatientsLikeMe participants, and were not independently verified. The review does not advise ketogenic diets for ALS because of their frequent side effects.

Why this matters

This means ketogenic diets should not be considered an established treatment for people living with ALS. A clinical trial enrolled only one person and had no control group, so it could not show whether the diet helped. ALSUntangled says another trial is needed.

Limitations and context

This is an independent expert review, not a new clinical trial. The evidence included a flawed preclinical study, unverified individual reports, and a one-person uncontrolled trial. The review called for further research and did not establish whether ketogenic diets benefit people with ALS.

Summarised by Compass 10 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?